A kidney transplant is not simply a procedure to book overseas. For New Zealand patients living with advanced kidney disease, kidney transplant eligibility in India depends on two equally serious questions: whether transplantation is clinically right for the recipient, and whether a suitable donor and lawful pathway are in place. Getting clear answers early can prevent distressing delays later.

India has highly experienced transplant teams, accredited multi-specialty hospitals and access to advanced dialysis, imaging, immunology and intensive care. Yet the strongest outcomes begin with careful screening, transparent documentation and a plan for follow-up once you are home.

Kidney transplant eligibility in India: the clinical starting point

Most people are considered for transplantation when they have end-stage kidney disease or kidney function is expected to decline to that point. This may be caused by diabetes, high blood pressure, polycystic kidney disease, glomerulonephritis, autoimmune disease or other long-term conditions.

A transplant specialist will assess whether the likely benefits outweigh the surgical and lifelong medical risks. Dialysis status matters, but it is not the only factor. Some patients may be assessed for a pre-emptive transplant before dialysis starts, while others need a period of dialysis to stabilise their health before surgery.

Age alone does not automatically exclude someone from transplantation. A fit older person may be suitable, while a younger person with uncontrolled infection or severe heart disease may need further treatment first. The decision is individual and should be made by a multidisciplinary transplant team, not from a single test result.

What recipient assessments usually cover

The hospital will usually request recent reports from your nephrologist and dialysis unit, then arrange or repeat key tests. These commonly include blood group and tissue typing, kidney function, full blood count, liver tests, infection screening, heart assessment, chest imaging and cancer screening appropriate to your age and history.

The team also reviews conditions that can affect anaesthetic or surgical safety. Significant coronary artery disease, poorly controlled diabetes, serious lung disease, active liver disease and circulation problems may require treatment or specialist clearance before a transplant can proceed.

An active infection needs to be resolved first. This can include tuberculosis, untreated dental infection, hepatitis requiring management, or an infected dialysis access site. A recent or active cancer may also delay eligibility, depending on its type, stage, treatment response and the specialist advice available. This is because anti-rejection medicines suppress the immune system after transplantation.

Mental wellbeing, medication adherence and reliable support at home are assessed too. These are not judgement calls. Anti-rejection medicines must be taken precisely for life, and patients need a realistic plan for blood tests, prescriptions and urgent medical review after returning to New Zealand.

Donor eligibility and India’s legal requirements

For many families, the donor pathway is the part that requires the most planning. A living donor must be an adult who is medically fit, gives informed consent freely and has compatible blood and tissue results where possible. Their long-term health is treated as a priority, not as secondary to the recipient’s needs.

Donor testing is comprehensive. It typically examines blood pressure, kidney function, diabetes risk, urine protein, anatomy of both kidneys, infection status, heart health and psychological readiness. A potential donor can be declined even if they are keen to help, particularly where donation could create an unacceptable future health risk.

India’s transplant system is governed by the Transplantation of Human Organs and Tissues Act and related rules. Living donation is closely regulated to prevent commercial organ trading. Spouses and close blood relatives, such as parents, children, siblings, grandparents and grandchildren, may be considered under the recognised related-donor pathway, subject to evidence of the relationship and hospital assessment.

Where a donor is not a recognised close relative, an Authorisation Committee review is generally required. The committee examines the relationship, motivations, financial circumstances and consent process to confirm that no payment, coercion or inducement is involved. This review can take time, particularly when documents from another country need verification.

For overseas patients, hospitals may ask for passports, visas, marriage or birth certificates, family records, photographs, affidavits and supporting letters from relevant authorities. Requirements can differ between states, hospitals and individual cases. It is wise to obtain a document checklist before travel rather than assuming paperwork can be completed after arrival.

What about deceased-donor transplants?

A deceased-donor transplant uses a kidney donated after death and allocated through established waiting-list systems. Availability is limited, allocation is governed by local rules and priority is based on clinical and ethical criteria. International patients should not assume this pathway will be available or quick.

For New Zealanders considering India, a living related-donor pathway is often more practical where it is clinically and legally appropriate. However, no donor should feel pressured to proceed, and compatibility should never be treated as a guarantee of approval.

Compatibility matters, but it is not the whole decision

Blood group compatibility is usually checked first, followed by crossmatching and other immunology tests. A positive crossmatch can mean the recipient has antibodies likely to attack the donor kidney. In some circumstances, a specialist team may discuss desensitisation treatment or other options, but these approaches bring added complexity, cost and infection risk.

Even with a compatible donor, transplant teams look at the whole picture: the donor’s safety, recipient health, surgical risk, infection exposure, the ability to afford lifelong medicines and the arrangements for follow-up. A technically possible transplant is not always the right immediate choice.

Patients with complex histories, including previous transplants, multiple blood transfusions or high antibody levels, should expect a more detailed immunology review. Sending complete records in advance helps the hospital advise whether a pathway is realistic before anyone commits to travel.

Planning safely from New Zealand

A kidney transplant involves more than the surgery itself. Recipients usually need to remain close to the hospital for monitoring in the early recovery period, while donors also require post-operative review before they are fit to fly. The exact stay depends on recovery, laboratory results, complications and the surgeon’s advice.

Before travelling, ask for a written treatment plan that sets out the proposed assessments, anticipated hospital stay, likely medicines, exclusions and circumstances that could change the estimate. Transplant costs vary widely based on donor work-up, recipient complexity, intensive care needs, immunology treatment and the length of admission. A lower initial quote is not meaningful if major clinical components are unclear.

You should also speak with your New Zealand nephrologist, dialysis provider and GP about continuity of care. Arrange how dialysis will be managed before travel if needed, who will prescribe and monitor anti-rejection medicines after you return, and where urgent concerns will be assessed. Private travel insurance may exclude planned transplantation or pre-existing kidney disease, so insurance guidance needs careful attention.

Companions play a practical role as well. They may need accommodation close to the hospital, help with meals and transport, and a clear understanding of warning signs such as fever, reduced urine output, wound redness, vomiting or sudden swelling. Early complications are treatable, but they should never be managed by waiting it out.

Questions worth asking before you commit

A reputable hospital should be comfortable answering direct questions about transplant-team credentials, hospital accreditation, infection-control procedures, intensive care access, donor committee processes and how it manages complications. Ask who will be responsible for your case, not just the name of the hospital.

It is also reasonable to ask what happens if the donor is ruled out, if crossmatch results are unsuitable, or if your own testing identifies a condition that needs treatment first. These are disappointing outcomes, but discovering them before surgery protects everyone involved.

Wellaway Meditours can help New Zealand patients coordinate records, hospital discussions, travel logistics and support arrangements, while keeping the clinical decision where it belongs: with qualified transplant specialists and an appropriately informed patient and donor.

The right next step is not to rush towards a date. It is to obtain a thorough, independent assessment, make space for the donor’s free decision, and build a follow-up plan that protects the transplant long after the flight home.